{
    "id": 32691,
    "fullName": "MTOR G2510D",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "MTOR G2510D lies within the PI3K/PI4K domain of the mTOR protein (UniProt.org). G2510D has been identified in the scientific literature (PMID: 31335987), but has not been biochemically characterized and therefore, its effect on Mtor protein function is unknown (PubMed, Mar 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 18013,
                    "pubMedId": 31335987,
                    "title": "PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31335987"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2475,
        "geneSymbol": "MTOR",
        "terms": [
            "MTOR",
            "FRAP",
            "FRAP1",
            "FRAP2",
            "RAFT1",
            "RAPT1",
            "SKS"
        ]
    },
    "variant": "G2510D",
    "createDate": "03/04/2020",
    "updateDate": "03/04/2020",
    "referenceTranscriptCoordinates": {
        "id": 188180,
        "transcript": "NM_004958",
        "gDna": "chr1:g.11108286C>T",
        "cDna": "c.7529G>A",
        "protein": "p.G2510D",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20715,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, Afinitor (everolimus) treatment resulted in stable disease with a progression-free survival of 2 months in a patient with renal cell carcinoma harboring MTOR G2510D (PMID: 31335987).",
            "molecularProfile": {
                "id": 35307,
                "profileName": "MTOR G2510D"
            },
            "therapy": {
                "id": 735,
                "therapyName": "Everolimus",
                "synonyms": null
            },
            "indication": {
                "id": 4450,
                "name": "renal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 18013,
                    "pubMedId": 31335987,
                    "title": "PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31335987"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35307,
            "profileName": "MTOR G2510D",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 188180,
            "transcript": "NM_004958",
            "gDna": "chr1:g.11108286C>T",
            "cDna": "c.7529G>A",
            "protein": "p.G2510D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 188181,
            "transcript": "XM_005263438",
            "gDna": "chr1:g.11108286C>T",
            "cDna": "c.7529G>A",
            "protein": "p.G2510D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}